Hannay, J; Davis, J J; Yu, D et al. (2007) Isolated limb perfusion: a novel delivery system for wild-type p53 and fiber-modified oncolytic adenoviruses to extremity sarcoma. Gene Ther 14:671-81
|
Das, Parimal; Kotilingam, Dhanasekaran; Korchin, Borys et al. (2007) High prevalence of p53 exon 4 mutations in soft tissue sarcoma. Cancer 109:2323-33
|
Hannay, Jonathan A F; Liu, Juehui; Zhu, Quan-Sheng et al. (2007) Rad51 overexpression contributes to chemoresistance in human soft tissue sarcoma cells: a role for p53/activator protein 2 transcriptional regulation. Mol Cancer Ther 6:1650-60
|
Zhang, Lianglin; Hannay, Jonathan A F; Liu, Juehui et al. (2006) Vascular endothelial growth factor overexpression by soft tissue sarcoma cells: implications for tumor growth, metastasis, and chemoresistance. Cancer Res 66:8770-8
|
Liu, Jue; Zhan, Maocheng; Hannay, Jonathan A F et al. (2006) Wild-type p53 inhibits nuclear factor-kappaB-induced matrix metalloproteinase-9 promoter activation: implications for soft tissue sarcoma growth and metastasis. Mol Cancer Res 4:803-10
|
Zhan, Maocheng; Yu, Dihua; Liu, Juehui et al. (2005) Transcriptional repression of protein kinase Calpha via Sp1 by wild type p53 is involved in inhibition of multidrug resistance 1 P-glycoprotein phosphorylation. J Biol Chem 280:4825-33
|
Zhang, Lianglin; Yu, Dihua; Hicklin, Daniel J et al. (2002) Combined anti-fetal liver kinase 1 monoclonal antibody and continuous low-dose doxorubicin inhibits angiogenesis and growth of human soft tissue sarcoma xenografts by induction of endothelial cell apoptosis. Cancer Res 62:2034-42
|
Hu, Mei; Nicolson, Garth L; Trent 2nd, Jonathan C et al. (2002) Characterization of 11 human sarcoma cell strains: evaluation of cytogenetics, tumorigenicity, metastasis, and production of angiogenic factors. Cancer 95:1569-76
|
Zhan, M; Yu, D; Lang, A et al. (2001) Wild type p53 sensitizes soft tissue sarcoma cells to doxorubicin by down-regulating multidrug resistance-1 expression. Cancer 92:1556-66
|
Zhang, L; Yu, D; Hu, M et al. (2000) Wild-type p53 suppresses angiogenesis in human leiomyosarcoma and synovial sarcoma by transcriptional suppression of vascular endothelial growth factor expression. Cancer Res 60:3655-61
|
Showing the most recent 10 out of 19 publications